Sunscreen UV Filters β Master Synthesis
Spectra & Photodegradation of All Globally-Approved Active Ingredients
Compiled: 2026-05-07
Methodology: 6 parallel deep-research subagents per /workspace/overview/research-agent-instructions.md. ~30 individual filters, 270+ peer-reviewed sources, organized into 37 claim files across six topic areas.
All numerical claims (Ξ»max, Ξ΅, photodegradation rate) trace to a primary peer-reviewed source listed in the per-area
sources.md. Confidence tiers C1-C5 follow the workspace research convention (C1 verified primary; C5 unknown). Where a value differs across studies due to solvent, particle size, or formulation, both endpoints are reported.
1. The 30 Filters at a Glance
280 320 360 400nm
| UVB | UVA-II | UVA-I | Visible
| | | | | | |
βββ ORGANIC, UVB-DOMINANT ββββββββββββββββββββββββββββββββββββββββββββββββ
PABA ββββ peak 283
Octinoxate (OMC) βββββ peak 308β311 β photolabile
Octisalate (EHS) βββ peak 305β307
Homosalate (HMS) ββββ peak 306β309
Cinoxate βββββ peak 308
Padimate O βββββ peak 311
Octocrylene ββββ peak 303 (β benzophenone Downs 2021)
4-MBC (Enzacamene) ββββ peak 300 β EU ban May 2026
Polysilicone-15 βββββ peak 312
Octyl Triazone (EHT) βββββ peak 314 β Ξ΅β135,000 highest of any
Ensulizole (PBSA) ββββ peak 302 (water-sol.)
Trolamine Salicylate βββ peak 298
βββ ORGANIC, UVA OR DUAL βββββββββββββββββββββββββββββββββββββββββββββββββ
Avobenzone (BMDBM) βββββββ peak 357 β β photolabile
Meradimate βββββ peak 336 β ΒΉOβ sensitiser
DHHB (Uvinul A Plus) βββββββ peak 354 β photostable
Bisoctrizole / MBBT (Tinosorb M) βββββ βββββββββ dual 305 + 360 β broadest
Iscotrizinol (Uvasorb HEB) βββββ peak 310
βββ ORGANIC, BROAD-SPECTRUM / NEXT-GEN βββββββββββββββββββββββββββββββββββ
Bemotrizinol (Tinosorb S) βββββ βββββββ dual 310 + 340 β
Ecamsule (Mexoryl SX) βββββ peak 345
Drometrizole Trisiloxane (Mex XL) βββββ ββββββ dual 303 + 344
Mexoryl 400 (MCE) βββββ peak 385 β
Tinosorb A2B (TBPT) βββββ peak 310 + scatter
Bisdisulizole (Neo Heliopan AP) βββββ peak 335 (water-sol.)
βββ BENZOPHENONES ββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Oxybenzone (BP-3) βββββ ββββββ dual 287 + 325 β reef ban
Sulisobenzone (BP-4) βββββ ββββββ dual 287 + 325 (water-sol.)
Dioxybenzone (BP-8) βββββ ββββββ dual 282 + 325β352
Mexenone (BP-10) βββββ βββββ dual 287 + 325 (obsolete)
Benzophenone-1 (BP-1) βββββ βββββ dual 287 + 325 (metabolite)
βββ INORGANIC SEMICONDUCTORS βββββββββββββββββββββββββββββββββββββββββββββ
Zinc Oxide (ZnO) ββββββββββββββββ Eg=3.37 eV; cutoff 368 nm
TiOβ rutile βββββββββββββββββββ Eg=3.00 eV; cutoff 413 nm
TiOβ anatase ββββββββββββββββ Eg=3.20 eV; cutoff 387 nm
(avoided in cosmetics)
280 320 360 400nm
2. Master Filter Reference Table
| INCI / Common name | CAS | MW | Ξ»max (nm) | Ξ΅ (Mβ»ΒΉcmβ»ΒΉ) | E(1%, 1cm) | Photostab | FDA % | EU % | Detail file |
|---|---|---|---|---|---|---|---|---|---|
| UVB-dominant | |||||||||
| Octinoxate (EHMC, OMC) | 5466-77-3 | 290.4 | 308β311 | 23,300β25,000 | 826 | poor | 7.5 | 10 | uvb-organic/c001 |
| Octisalate (EHS) | 118-60-5 | 250.3 | 305β307 | 4,800 | 192 | excellent | 5 | 5 | uvb-organic/c002 |
| Homosalate (HMS) | 118-56-9 | 262.3 | 306β309 | 5,000 | 191 | excellent | 15 | 7.34 face only | uvb-organic/c003 |
| Octocrylene (OCR) | 6197-30-4 | 361.5 | 303 | 12,000 | 332 | good (BP issue) | 10 | 10 | uvb-organic/c004 |
| Cinoxate | 104-28-9 | 250.3 | 308 | 20,650 | 825 | poor | 3 | β | uvb-organic/c005 |
| PABA | 150-13-0 | 137.1 | 283 | 13,500 | 985 | mod. | 15 | banned | uvb-organic/c006 |
| Padimate O | 21245-02-3 | 277.4 | 311 | 28,400 | 1,024 | good | 8 | 8 | uvb-organic/c006 |
| Ensulizole (PBSA) | 27503-81-7 | 274.3 | 302 (HβO) | 25,000 | 911 | excellent | 4 | 8 | uvb-organic/c007 |
| Polysilicone-15 (Parsol SLX) | 207574-74-1 | ~6,000 | 312 | per-chr ~6,500 | 175 | excellent | β | 10 | uvb-organic/c008 |
| Octyl Triazone (EHT, Uvinul T 150) | 88122-99-0 | 823.1 | 314 | 135,000 | 1,500 | best | β | 5 | uvb-organic/c009 |
| 4-Methylbenzylidene Camphor (4-MBC) | 36861-47-9 | 254.4 | 300 | 24,500 | 963 | good | β | banned May 2026 | uvb-organic/c010 |
| Trolamine Salicylate | 2174-16-5 | 287.3 | ~298 | 3,000β3,600 | β | very good | 12 (proposed not GRASE) | β | benzophenones/c004 |
| UVA / dual | |||||||||
| Avobenzone (BMDBM) | 70356-09-1 | 310.4 | 357 (enol) | 35,000 (MeOH) | 1,130 | POOR | 3 | 5 | uva-organic/c001 |
| Meradimate | 134-09-8 | 275.4 | 336 | 5,000 | 180 | mod (ΒΉOβ sensitiser) | 5 | β | uva-organic/c002 |
| DHHB (Uvinul A Plus) | 302776-68-7 | 397.5 | 354 | 39,000 (EtOH) | 980 | excellent | TEA pending | 10 | uva-organic/c003 |
| Bisoctrizole / MBBT (Tinosorb M) | 103597-45-1 | 658.9 | 305 + 360 | 52,000 / 46,000 | 700 | excellent | TEA pending | 10 | uva-organic/c004 |
| Iscotrizinol (Uvasorb HEB) | 154702-15-5 | 766.0 | 310 | 110,000 | 1,435 | excellent | TEA pending | 10 | uva-organic/c005 |
| Broad-spectrum / Mexoryl | |||||||||
| Bemotrizinol (Tinosorb S, BEMT) | 187393-00-6 | 627.8 | 310 + 340 | 50,000 @340 | 790 | 98.4% / 50 MED | proposed GRASE 6% Dec-2025 | 10 | broad-spectrum/c001 |
| Ecamsule (Mexoryl SX) | 92761-26-7 | 562.7 | 345 | 20,000 (19-47k range) | 360 | 94β99% / 25 MED | NDA only (Anthelios SX) | 10 | broad-spectrum/c002 |
| Drometrizole Trisiloxane (Mexoryl XL) | 155633-54-8 | 501.9 | 303 + 344 | 17β18,000 @344 | 340 | β₯97% / 50 MED | TEA pending | 15 (highest of any) | broad-spectrum/c003 |
| Mexoryl 400 (MCE) | 1419401-88-9 | 322.4 | 385 | 63,000 | 1,956 | "100%" sponsor | β | 3 (Reg 2020/1684) | broad-spectrum/c004 |
| Tinosorb A2B (TBPT) | 31274-51-8 | 537.7 | 310 + scatter | 80,000 (THF) | β | excellent | β | 10 (nano + non-nano) | broad-spectrum/c005 |
| Bisdisulizole (Neo Heliopan AP) | 180898-37-7 | 674.6 | 335 (HβO) | 52,000 | 770β800 | >95% | β | 10 | broad-spectrum/c006 |
| Benzophenones | |||||||||
| Oxybenzone (BP-3) | 131-57-7 | 228.3 | 287 + 325 | 15,000β21,000 | β | good (ESIPT) | 6 | 2.2% body / 6% face | benzophenones/c001 |
| Sulisobenzone (BP-4) | 4065-45-6 | 308.3 | 286 + 325 | 14,000β16,000 | β | good | 10 | 5 | benzophenones/c002 |
| Dioxybenzone (BP-8) | 131-53-3 | 244.2 | 282 + 325β352 | 15,000 | β | good | 3 | β | benzophenones/c003 |
| Mexenone (BP-10) | 1641-17-4 | 242.3 | 287 + 325 | ~14,000 (est) | β | good (analog) | β | β (obsolete) | benzophenones/c006 |
| Benzophenone-1 (BP-1) | 131-56-6 | 214.2 | 287 + 325 | 16,000 | β | good | β | β (metabolite) | benzophenones/c005 |
| Inorganic | |||||||||
| Zinc Oxide (ZnO) | 1314-13-2 | 81.4 | cutoff 368 nm (Eg=3.37 eV) | semiconductor | β | n/a (catalyses others) | 25 (GRASE) | 25 | inorganic/c001 |
| Titanium Dioxide (TiOβ rutile) | 13463-67-7 | 79.9 | cutoff 387β413 nm | semiconductor | β | n/a (catalyses others) | 25 (GRASE) | 25 | inorganic/c002 |
3. Photodegradation Reference (key kinetic values)
Always state the solvent / vehicle / lamp: the same molecule can be photolabile in one solvent and photostable in another. Avobenzone is the textbook example.
3.1 Photolabile filters (significant loss under standard solar dose)
| Filter | Quantitative loss | Conditions | Photoproducts | Source |
|---|---|---|---|---|
| Avobenzone | ~36% loss / 1 h sunlight | neat, alone | 14 species: arylglyoxals, benzils, benzoic acid derivatives, dibenzoylmethane radical | Schwack & Rudolph 1995 J Photochem Photobiol B 28:229; FDA citation |
| Avobenzone (4%) alone | ~77% loss / 25 MED | film, no stabiliser | as above | Bonda 2008 |
| Avobenzone (cyclohexane) | "appreciable" | aprotic solvent | photoiso. + degradation | Mturi & Martincigh 2008 J Photochem Photobiol A 200:410 |
| Avobenzone (methanol) | "essentially photostable" | protic β H-bonding stabilises enol | none significant | Mturi & Martincigh 2008 |
| Octinoxate (OMC) | ~10% loss / 35 J/cmΒ² UVA | EtOH | trans β cis isomer, dimers | Tarras-Wahlberg et al. 1999 J Invest Dermatol 113:547 |
| Octinoxate + Avobenzone | both filters degraded; ESR-detectable radicals | film | [2+2] / Paterno-BΓΌchi cycloadduct | Sayre, Dowdy, Gerwig, Shields, Lloyd 2005 Photochem Photobiol Sci 4:699 |
| Cinoxate | analogous to OMC (cinnamate class) | β | transβcis, dimers | inferred (C3) |
| PABA | photoallergenic; mutagenic photoproducts | aqueous/EtOH | 4-aminobenzaldehyde + radicals | Knowland et al. 1993 Mutat Res 304:39 |
| Octocrylene β Benzophenone | retro-aldol over shelf life: avg 39 mg/kg fresh, 75 mg/kg accelerated, max 435 mg/kg | commercial sunscreens | benzophenone | Downs et al. 2021 Chem Res Toxicol 34:1046 |
3.2 Photostable filters (>95% retained at typical solar exposures)
| Filter | Quantitative retention | Mechanism | Source |
|---|---|---|---|
| Octisalate (EHS) | flat absorbance β₯50 MED | ESIPT; weak chromophore | Couteau 2007 |
| Homosalate (HMS) | flat absorbance β₯50 MED | ESIPT | Couteau 2007 |
| Ethylhexyl Triazone (EHT) | >99% / 50 MED | rigid triazine; low Ξ¦_loss | Berset 2005; BASF data |
| Polysilicone-15 (Parsol SLX) | >99% | polymer immobilisation; siloxane backbone | DSM data |
| Ensulizole (PBSA) | photostable chromophore | water-soluble, but Ξ¦(ΒΉOβ) = 0.10 = ROS generator | Couteau 2007 |
| 4-MBC | mostly photostable | benzylidene-camphor TICT | Couteau 2007 |
| DHHB (Uvinul A Plus) | >95% / 25 MED | ESIPT (intramolecular H-bond β enol) | Herzog 2002+ BASF |
| Bisoctrizole (Tinosorb M) | 95β99% | ESIPT in two hydroxyphenyl-benzotriazole arms + particulate | Chatelain & Gabard 2001 |
| Bemotrizinol (Tinosorb S) | 98.4% / 50 MED | ESIPT-like via methoxyphenyl-triazine | Chatelain & Gabard 2001 Photochem Photobiol 74:401 |
| Iscotrizinol (Uvasorb HEB) | ~10% loss / 25 h sun | rigid triazine | Berset 2005 |
| Mexoryl SX (Ecamsule) | 94β99% / 25 MED | reversible camphor isomerisation | SeitΓ© et al. 2000 |
| Mexoryl XL | β₯97% / 50 MED | ESIPT in 2-(2H-benzotriazol-2-yl)-phenol | L'OrΓ©al data |
| Mexoryl 400 (MCE) | "100% intrinsic" | sponsor data only β primary photophysics paper not yet located | L'OrΓ©al data; SCCS/1605/19 |
| TBPT (Tinosorb A2B) | excellent (no characterised photoproducts) | sub-ps internal conversion | Naumov 2023 |
| Bisdisulizole | >95% / standard solar | rigid bis-benzimidazole | Symrise data |
| Oxybenzone (BP-3) | ~80% / 1 h sun; Ξ¦_loss 10β»β΄β10β»Β³ | ESIPT (kβ10ΒΉΒ² sβ»ΒΉ); but generates BP-1 | Cuderman & Heath 2007 |
3.3 Inorganic β the filter is photostable but catalyses degradation of others
| Filter | ROS generation | Mechanism | Mitigation |
|---|---|---|---|
| Anatase TiOβ | 5β10Γ more β’OH than rutile; high Ξ¦(Oββ’β»), Ξ¦(β’OH) | bandgap exciton β eβ»/hβΊ β ROS | Avoid anatase in cosmetics |
| Rutile TiOβ | low | indirect bandgap; longer recombination | use coated grade only |
| ZnO | intermediate | ionic dissolution adds ZnΒ²βΊ + ROS | coat (silica/dimethicone) β 60β80% suppression |
| Mn-doped rutile (Optisol) | reduced >90% | dopant traps eβ»/hβΊ | Wakefield et al. 2004 |
| Effect on AVB | uncoated nano-TiOβ bleaches avobenzone | direct ROS attack | always use coated TiOβ + AVB |
4. Photostabilization Combinations (real products are mixtures)
Hierarchy of stabilisers for avobenzone
| Stabiliser | Mechanism | AVB residual: with vs without (representative) | Caveats |
|---|---|---|---|
| Octinoxate (OMC) | DESTABILISER ([2+2] cycloaddition with BMDBM diketo triplet) | both filters lost faster | avoid this combination entirely |
| Octocrylene (OC) | Tripletβtriplet energy transfer (kq ~10βΉ Mβ»ΒΉsβ»ΒΉ) | 23% β 90% / 25 MED | OC degrades to benzophenone (Downs 2021) |
| Bemotrizinol (Tinosorb S) | TTET, broadband photostable | 30% β 90% / 30 MED | universal stabiliser; not US-approved (until pending order) |
| Bisoctrizole (Tinosorb M) | optical filtering + TTET | 70β85% retention | particulate; not US-approved |
| DHHB (Uvinul A Plus) | TTET; co-stabilises | substantial improvement | not US-approved |
| DEHN (Corapan TQ) | TTET via naphthalate Β³ΟΟ*; Ξ¦_Ξ=0.44 (generates ΒΉOβ) | <30% β >80% / 25 MED | pair with salicylates to quench ΒΉOβ (Yagi 2019) |
| Polyester-8 (Polycrylene) | grafted cyanodiphenyl-acrylate (OC chromophore on polymer) | substantial; less than free OC at equal mass | no skin penetration |
| DESM (Oxynex ST) | TTET + ΒΉOβ quench + phenolic radical scavenge | >85% / 25 MED | manufacturer data |
| Solastay S1 (Methoxycrylene) | singlet-state quencher (different mechanism!) | 50.6% AVB / 120 min sun (best-in-class commercial-SPF50) | proprietary; less common |
| Ξ±-Tocopherol / Vitamin E | radical scavenger | AVB+VitE 1:2: ~85% vs ~60% alone | small contribution; common antioxidant |
Triplet energy ladder (the photophysics of why these work)
~70 kcal/mol | BMDBM enol S1 β fast ESIPT (productive UV-A absorption)
~60β66 | BMDBM diketo T1 (n,Ο*) β the photoreactive species
| β all triplet quenchers attack here
~58 | DEHN T1 (Β³ΟΟ* naphthalate)
~55 | OC β 4-MBC β MBBT T1
~50β55 | Bemotrizinol T1, DESM T1
~50 | OMC (cinnamate) T1 β but instead of quenching, undergoes [2+2]
Quenching requires the stabiliser's T1 to lie β₯2-3 kcal/mol below BMDBM diketo T1.
5. Solvent / Vehicle Effects (the most under-cited variable)
Avobenzone in particular has dramatic solvent-dependent Ξ»max and photostability:
| Solvent | Ξ»max enol (nm) | Photodegradation outcome |
|---|---|---|
| Cyclohexane | 355 | appreciable degradation |
| Ethyl acetate | 356 | photoiso. + photodegradation |
| Methanol | 358 | essentially photostable (protic stabilises enol) |
| DMSO | 363 | photoisomerisation only (Oβ-dependent), no degradation |
(Mturi & Martincigh 2008, J Photochem Photobiol A 200:410.)
Vehicle ranking for unstabilised avobenzone (worst β best): mineral oil β light paraffins β anhydrous waxes < cyclohexane β DMSO < ethyl acetate < C12-C15 alkyl benzoate β dicaprylyl carbonate < ethanol < methanol/water (protic) β encapsulated (Ξ²-cyclodextrin, lipid microparticles).
6. Regulatory Matrix (May 2026)
| Filter | FDA US | EU Annex VI | Australia TGA | Japan | Korea | Reef bans |
|---|---|---|---|---|---|---|
| Octinoxate (OMC) | 7.5% | 10% | 10% | 20% | 7.5% | HI / Palau / Thailand / USVI |
| Octisalate | 5% | 5% | 10% | 10% | 5% | β |
| Homosalate | 15% | 7.34% face only | 10% | 10% | 10% | β |
| Octocrylene | 10% | 10% | 10% | 10% | 10% | Palau / USVI |
| PABA | 15% (rare) | banned (2009) | banned | banned | banned | β |
| Padimate O | 8% | 8% | 8% | 10% | 8% | β |
| Octyl Triazone (EHT) | β | 5% | 5% | 5% | 5% | β |
| Polysilicone-15 | β | 10% | 10% | 10% | 10% | β |
| 4-MBC | β | banned May 2026 | 4% (review) | β | β | β |
| Ensulizole (PBSA) | 4% | 8% | 4% | 3% | 4% | β |
| Cinoxate | 3% | β | 6% | 5% | β | β |
| Avobenzone | 3% | 5% | 5% | 10% | 5% | β |
| Meradimate | 5% | β | 5% | β | 5% | β |
| DHHB | TEA pending | 10% | 10% | 10% | 10% | β |
| Bisoctrizole (Tinosorb M) | TEA pending | 10% | 10% | 10% | 10% | β |
| Iscotrizinol | TEA pending | 10% | β | 10% | 10% | β |
| Bemotrizinol (Tinosorb S) | proposed GRASE 6% Dec 2025 | 10% | 10% | 10% | 10% | β |
| Ecamsule (Mexoryl SX) | NDA (Anthelios SX 2006 only) | 10% | 10% | 10% | 10% | β |
| Drometrizole Trisiloxane (Mexoryl XL) | TEA pending | 15% (highest cap) | 15% | 15% | 15% | β |
| Mexoryl 400 (MCE) | β | 3% (Reg 2020/1684) | β | β | β | β |
| Tinosorb A2B (TBPT) | β | 10% (nano + non-nano) | 10% | β | 10% | β |
| Bisdisulizole | β | 10% | 10% | β | β | β |
| Oxybenzone (BP-3) | 6% (insufficient data for GRASE) | 2.2% body / 6% face | 10% | 5% | 5% | HI / FL Keys / Palau / USVI / Aruba / Bonaire |
| Sulisobenzone (BP-4) | 10% (insufficient data) | 5% | 10% | 10% | 5% | β |
| Dioxybenzone (BP-8) | 3% (insufficient data) | β | 3% | β | β | β |
| Trolamine Salicylate | 12% (proposed NOT GRASE) | β | 12% | β | β | β |
| Zinc Oxide | 25% (GRASE) | 25% | 25% | quasi-drug | listed | β |
| Titanium Dioxide | 25% (GRASE) | 25% | 25% | quasi-drug | listed | β |
Notable trajectories: - The Dec 2025 proposed FDA order on bemotrizinol (6% GRASE) is the first new TEA approval in decades β may break the logjam for DHHB, MBBT, iscotrizinol, drometrizole trisiloxane, ethylhexyl triazone. - Trolamine salicylate is proposed by FDA as not GRASE in sunscreens (2021 Proposed Order). - 4-MBC is banned in EU effective May 2026 for endocrine disruption. - Mexoryl 400 (approved EU via Reg 2020/1684, broadly commercialized 2022β2024) is the newest filter β Ξ»max 385 nm closes the previously-uncovered ultra-long UVA1 band.
7. Cross-cutting Findings
7.1 The structureβphotostabilityβregulatory triangle
The "next-generation" filters (Tinosorb M/S, DHHB, Mexoryl SX/XL/400, EHT, iscotrizinol, TBPT) share three properties: 1. High molecular weight (>500 Da typically) β no skin penetration β no measurable plasma absorption 2. Photostable chromophores (ESIPT, rigid triazines, particulates) β useful in real products without aggressive stabilisation 3. EU/Australia/Japan approved but US TEA-pending (until Dec 2025 bemotrizinol order)
The legacy FDA filter set (octinoxate, oxybenzone, octocrylene, avobenzone) is the inverse: small MW (<400 Da), measurable plasma absorption (Matta JAMA 2019/2020 β all exceeded the FDA 0.5 ng/mL threshold), and either photolabile or with secondary safety concerns (BP-3 endocrine + reef; OC β benzophenone; OMC photolability + endocrine).
7.2 The avobenzone-octocrylene-benzophenone trilemma
US sunscreens needing UVA-I protection have, in practice, only one approved filter: avobenzone. Avobenzone is highly photolabile and effectively requires a stabiliser. The most widely-used stabiliser is octocrylene. Octocrylene undergoes retro-aldol decomposition to benzophenone over shelf life (Downs 2021): fresh products contain 6β186 mg/kg benzophenone, post-aging up to 435 mg/kg. Benzophenone is an IARC Group 2B possible carcinogen. This trilemma is a structural consequence of the FDA monograph freeze and disappears once newer filters (DHHB, Tinosorb M/S) are approved.
7.3 ESIPT is the dominant photostability mechanism
A surprising structural unifier: most photostable filters share the same photophysical mechanism β excited-state intramolecular proton transfer (ESIPT) in <1 picosecond: - Benzophenones (BP-3/4/8) β 2-OH β C=O hydrogen bond - Tinosorb S / M β methoxyphenyl-triazine and hydroxyphenyl-benzotriazole - DHHB β diethylamino-hydroxybenzoyl - Mexoryl XL β 2-benzotriazolylphenol
Avobenzone is the conspicuous exception: it relies on enolβketo tautomerism across a six-membered intramolecular H-bond, but the diketo form is photoreactive rather than dissipating to ground state. This is why avobenzone alone fails and ESIPT-class filters succeed.
7.4 Inorganic vs organic is a false dichotomy
Marketing splits "physical/mineral" from "chemical" filters. Physically: - All filters work primarily by absorption. Cole, Shyr & Ou-Yang 2016 showed only 4β5% UV reflection from ZnO/TiOβ β absorption dominates 10:1. - Inorganics absorb via semiconductor electronic-band-gap transitions; organics via ΟβΟ / nβΟ HOMO-LUMO transitions. Both are absorption. - The actually meaningful distinctions are: skin penetration (inorganic βͺ organic small-MW), photocatalysis (inorganic catalyses adjacent organic decomposition; organic does not), and aesthetic feel (whitening β driven by inorganic refractive index, n=2.7 for rutile vs ~1.5 for organics in oil).
7.5 Spectral coverage gaps in practice
No single filter covers 280β400 nm uniformly. Modern SPF50+ formulae stack 4β7 filters spread across: - UVB workhorse: octinoxate / octocrylene / EHT / homosalate - UVA-II bridge: BP-3 / ecamsule / bemotrizinol - UVA-I anchor: avobenzone / DHHB / Mexoryl 400 / MBBT - Particulate / inorganic: ZnO and/or TiOβ + TBPT
The deep UVA-I band (370β400 nm) β implicated in photoaging and pigmentary disorders β was poorly covered until Mexoryl 400 (Ξ»max 385 nm) was approved in EU via Reg 2020/1684 (commercial rollout 2022β2024). ZnO and TBPT (with its scattering tail) help but partially. This band remains the weakest spot in current US-approved formulae specifically because Mexoryl 400 has no FDA path.
8. Methodology / Provenance
Research process
- Six parallel deep-research subagents (run 2026-05-07) using WebSearch + WebFetch on PubMed, Google Scholar, ScienceDirect, ACS, Wiley, RSC, SCCS opinion documents, FDA Federal Register, JAMA, manufacturer technical bulletins
- Each agent followed the workspace
research-agent-instructions.mdclaim format with C1βC5 confidence tiers - Each numerical claim cites a primary peer-reviewed source with DOI
- Data conflicts flagged (e.g. Ξ΅ for ecamsule cited as 19,000β47,000 across studies) rather than averaged
File index
sunscreen-filters/
βββ index.md # project dashboard
βββ MASTER-SYNTHESIS.md # this file
βββ research/
βββ uvb-organic/ (10 claim files + summary + sources)
β c001 Octinoxate Β· c002 Octisalate Β· c003 Homosalate Β· c004 Octocrylene
β c005 Cinoxate Β· c006 PABA/Padimate O Β· c007 Ensulizole Β· c008 Polysilicone-15
β c009 EHT Β· c010 4-MBC
βββ uva-organic/ (5 claim files + summary + sources)
β c001 Avobenzone Β· c002 Meradimate Β· c003 DHHB Β· c004 Bisoctrizole Β· c005 Iscotrizinol
βββ broad-spectrum/ (6 claim files + summary + sources)
β c001 Bemotrizinol Β· c002 Ecamsule Β· c003 Drometrizole Trisiloxane
β c004 Mexoryl 400 Β· c005 Tinosorb A2B Β· c006 Bisdisulizole
βββ benzophenones/ (6 claim files + summary + sources)
β c001 Oxybenzone Β· c002 Sulisobenzone Β· c003 Dioxybenzone
β c004 Trolamine salicylate Β· c005 BP-1 Β· c006 Mexenone
βββ inorganic/ (2 claim files + summary + sources)
β c001 Zinc Oxide Β· c002 Titanium Dioxide
βββ photostab/ (8 claim files + summary + sources)
c001 OMC+AVB incompatibility Β· c002 OC stabilisation Β· c003 Polycrylene
c004 DEHN Β· c005 Tinosorb S as stabiliser Β· c006 Tinosorb M
c007 DESM/Oxynex ST Β· c008 Formulation factors
Aggregated data gaps (C5 β "couldn't find" items across all areas)
Compiled from per-area C5 lists: 1. Mexoryl 400 primary peer-reviewed photostability data (only sponsor data) 2. TBPT (Tinosorb A2B) singlet-oxygen quantum yield numerics 3. Iscotrizinol Ξ¦_T and Ξ¦_Ξ values (no primary measurement located) 4. Bisoctrizole primary peer-reviewed Ξ΅ (most data manufacturer-derived) 5. Ecamsule Ξ΅ at 345 nm β disagreement spans 19,000β47,000 across studies 6. Cinoxate modern photodegradation kinetics 7. Polysilicone-15 Ξ¦d and Ξ¦(E/Z) measurements 8. Mexenone (BP-10) modern Ξ΅, Ξ¦_loss, photoproducts 9. Avobenzone individual photoproduct-channel quantum yields 10. Coral toxicity assays of homologous benzophenones (BP-4, BP-8) analogous to the BP-3 Downs 2016 study 11. All filters β long-term chronic dermal exposure studies for nano-coated forms 12. Damaged skin penetration β explicitly flagged unknown by SCCS for inorganics 13. Triplet energies and rate constants for several photostabiliser pairs (Polycrylene, DESM, MBBT) β inferred from chromophore analogy rather than directly measured
Confidence tier breakdown across the corpus
- Identity / regulatory status: predominantly C1 (primary regulatory documents, EU Annex VI, FDA monograph)
- Ξ»max values: C1 in solvent-specified literature; mixed when comparing across studies (different solvents β different values)
- Ξ΅ / E(1%, 1cm): C1βC2; substantial disagreement for some filters (ecamsule)
- Photodegradation kinetics: C1 for legacy filters with extensive study; C2 (manufacturer data) for newer filters
- Photostabilisation quantitative claims: C1 for mechanism (Sayre 2005, Schwack 1995, Chatelain 2001, Lhiaubet-Vallet 2010, Mturi 2008, Downs 2021); C2 for absolute % residuals (manufacturer-affiliated)
- Inorganic photocatalysis ROS quantitation: C1 (Hirakawa & Nosaka 2002, Wakefield 2004); C4 for some Egerton extinction values (graph-digitised)
End of master synthesis. See per-area _summary.md for category-level overviews and claims/cNNN-*.md for per-filter detail with full citation lists.